TMO Financial Facts
Product revenues: 3.87BTotal revenues: 4.49B
See Full Income Statement
Total Liabilities & Shareholders' Equity: 48.01B
Property, Plant and Equipment at Cost, Net: 2.6B
See Full Balance Sheet
Thermo Fisher Scientific, Inc. (TMO) Earnings
|
Expand Research on TMO
| Next EPS Date | 7/24/24 *Est. | EPS Growth Rate | +1.6% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +1.2% | Revenue Growth Rate | -3.5% *Last Qtr. |
| Average % Move 1-Wk after EPS | -2.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/28/22 |  |
Q122 | $7.25 | $6.18 | +$1.07 | $11.82B | $10.63B | N/A |  | | Details |
| 2/1/23 | Q422 | $5.40 | $5.22 | +$0.18 | $11.45B | $10.46B |  |
| | Details | |
| 7/28/22 | |
Q222 | $5.51 | $4.99 | +$0.52 | $10.97B | $9.97B | N/A | | | Details |
| 1/31/24 | Q423 | $5.67 | $5.64 | +$0.03 | $10.89B | $10.73B | = | | | Details | |
| 4/26/23 | Q123 | $5.03 | $5.03 | $0.00 | $10.71B | $10.65B | |
| | Details | |
| 2/2/22 | |
Q421 | $6.54 | $4.93 | +$1.61 | $10.7B | $8.84B | N/A | | | Details |
| 7/26/23 | Q223 | $5.15 | $5.43 | -$0.28 | $10.69B | $10.99B | |
| | Details | |
| 10/26/22 | Q322 | $5.08 | $4.81 | +$0.27 | $10.68B | $9.92B | N/A | | | Details |
